Sublingual atropine in the treatment of clozapine-induced sialorrhea

Schizophr Res. 2017 Apr:182:144-145. doi: 10.1016/j.schres.2016.10.039. Epub 2016 Nov 2.

Authors

Teofilo E Matos Santana¹, Noah A Capurso², Mohini Ranganathan², Gihyun Yoon²

Affiliations

¹ Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. Electronic address: teofilo.matossantana@yale.edu.
² Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; VA Connecticut Healthcare System, West Haven, CT, USA.

PMID: 27816262
DOI: 10.1016/j.schres.2016.10.039

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Sublingual
Adult
Antipsychotic Agents / adverse effects*
Atropine / administration & dosage
Atropine / pharmacology*
Clozapine / adverse effects*
Humans
Male
Middle Aged
Muscarinic Antagonists / administration & dosage
Muscarinic Antagonists / pharmacology*
Psychotic Disorders / drug therapy*
Schizophrenia / drug therapy*
Sialorrhea / chemically induced*

Substances

Antipsychotic Agents
Muscarinic Antagonists
Atropine
Clozapine